Supplemental Material - Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study
- Ivan A. Komerdelj (13766192)
- Mitchell S. Buckley (7422149)
- Paul A. D’Alessio (13766195)
- Delia S. Ziadat (13766198)
- Emir Kobic (13766201)
- Pooja Rangan (13007087)
- Sumit K. Agarwal (7422155)
- Nicole C. Tinta (13766204)
- Melanie J. Yerondopoulos (13766207)
- Sandra L. Kane-Gill (9093392)
Publication date
September 2022
DOIAbstract
Supplemental Material for Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study by Ivan A. Komerdelj, PharmD, Mitchell S. Buckley, PharmD, FASHP, FCCM, FCCP, BCCCP, Paul A. D’Alessio, PharmD, Delia S. Ziadat, PharmD, BCPS, Emir Kobic, PharmD, BCIDP, Pooja Rangan, MBBS, MPH, Sumit K. Agarwal, MBBS, MBA, Nicole C. Tinta, PharmD, MBA, BCPS, Melanie J. Yerondopoulos, PharmD, BCCCP, and Sandra L. Kane-Gill, PharmD, MSc, FCCM in Journal of Pharmacy Practice.</p
Add to ORKG